4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Rajesh Deshmukh, Lata Sharma, Muktika Tekade, Prashant Kesharwani, Piyush Trivedi, Rakesh K. Tekade. Force degradation behavior of glucocorticoid deflazacort by UPLC: isolation, identification and characterization of degradant by FTIR, NMR and mass analysis[J]. The Journal of Biomedical Research, 2016, 30(2): 149-161. DOI: 10.7555/JBR.30.20150074
Citation: Rajesh Deshmukh, Lata Sharma, Muktika Tekade, Prashant Kesharwani, Piyush Trivedi, Rakesh K. Tekade. Force degradation behavior of glucocorticoid deflazacort by UPLC: isolation, identification and characterization of degradant by FTIR, NMR and mass analysis[J]. The Journal of Biomedical Research, 2016, 30(2): 149-161. DOI: 10.7555/JBR.30.20150074

Force degradation behavior of glucocorticoid deflazacort by UPLC: isolation, identification and characterization of degradant by FTIR, NMR and mass analysis

More Information
  • Received Date: May 09, 2015
  • Revised Date: May 09, 2015
  • In this investigation, sensitive and reproducible methods are described for quantitative determination of deflazacort in the presence of its degradation product. The method was based on high performance liquid chromatography of the drug from its degradation product on reverse phase using Acquity UPLC BEH C18 columns (1.7 μm, 2.1 mm × 150 mm) using acetonitrile and water (40:60 V/V) at a flow rate of 0.2 mL/minute in UPLC. UV detection was performed at 240.1 nm. Deflazacort was subjected to oxidative, acid, base, hydrolytic,thermal and photolytic degradation. The drug was found to be stable in water and thermal stress, as well as under neutral stress conditions. However, forced-degradation study performed on deflazacort showed that the drug degraded under alkaline, acid and photolytic stress. The degradation products were well resolved from the main peak, which proved the stability-indicating power of the method. The developed method was validated as per ICH guidelines with respect to accuracy, linearity, limit of detection, limit of quantification, accuracy, precision and robustness, selectivity and specificity. Apart from the aforementioned, the results of the present study also emphasize the importance of isolation characterization and identification of degradant. Hence, an attempt was made to identify the degradants in deflazacort. One of the degradation products of deflazacort was isolated and identified by the FTIR, NMR and LC-MS study.
  • Related Articles

    [1]Reimhult Erik, Virk Mudassar Mumtaz. Hybrid lipopolymer vesicle drug delivery and release systems[J]. The Journal of Biomedical Research, 2021, 35(4): 301-309. DOI: 10.7555/JBR.35.20200206
    [2]Wang Le Yi, McKelvey George M., Wang Hong. Multi-outcome predictive modelling of anesthesia patients[J]. The Journal of Biomedical Research, 2019, 33(6): 430-434. DOI: 10.7555/JBR.33.20180088
    [3]Fengzhen Wang, Mingwan Zhang, Dongsheng Zhang, Yuan Huang, Li Chen, Sunmin Jiang, Kun Shi, Rui Li. Preparation, optimization, and characterization of chitosancoated solid lipid nanoparticles for ocular drug delivery[J]. The Journal of Biomedical Research, 2018, 32(6): 411-423. DOI: 10.7555/JBR.32.20160170
    [4]Christopher J. Danford, Zemin Yao, Z. Gordon Jiang. Non-alcoholic fatty liver disease: a narrative review of genetics[J]. The Journal of Biomedical Research, 2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045
    [5]Nina Schloemerkemper. Psychotic due to bath salts and methamphetamines: emergency cesarean section under general anesthesia[J]. The Journal of Biomedical Research, 2018, 32(4): 311-313. DOI: 10.7555/JBR.32.20180023
    [6]Qi Wang, Yimin Chao. Multifunctional quantum dots and liposome complexes in drug delivery[J]. The Journal of Biomedical Research, 2018, 32(2): 91-106. DOI: 10.7555/JBR.31.20160146
    [7]Anam Akhtar, Scarlet Xiaoyan Wang, Lucy Ghali, Celia Bell, Xuesong Wen. Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers[J]. The Journal of Biomedical Research, 2017, 31(3): 177-188. DOI: 10.7555/JBR.31.20160059
    [8]Xinli Liu. Bone site-specific delivery of siRNA[J]. The Journal of Biomedical Research, 2016, 30(4): 264-271. DOI: 10.7555/JBR.30.20150110
    [9]Rufeng Xie, Lizhong Wang, Hongguang Bao. Crystalloid and colloid preload for maintaining cardiac output in elderly patients undergoing total hip replacement under spinal anesthesia[J]. The Journal of Biomedical Research, 2011, 25(3): 185-190. DOI: 10.1016/S1674-8301(11)60024-9
    [10]Sundeep?S.?Tumber, Hong?Liu. Epidural abscess after multiple lumbar punctures for labour epidural catheter placement[J]. The Journal of Biomedical Research, 2010, 24(4): 332-335. DOI: 10.1016/S1674-8301(10)60046-2
  • Cited by

    Periodical cited type(11)

    1. Yu F, Zhao LX, Chu S. TCHH as a Novel Prognostic Biomarker for Patients with Gastric Cancer by Bioinformatics Analysis. Clin Exp Gastroenterol, 2024, 17: 61-74. DOI:10.2147/CEG.S451676
    2. Li K, Qiu Y, Liu X, et al. Biomimetic Nanosystems for the Synergistic Delivery of miR-144/451a for Oral Squamous Cell Carcinoma. Balkan Med J, 2022, 39(3): 178-186. DOI:10.4274/balkanmedj.galenos.2022.2021-11-1
    3. Yu CC, Chan MWY, Lin HY, et al. IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell Carcinoma. Front Oncol, 2021, 11: 647175. DOI:10.3389/fonc.2021.647175
    4. Amiri-Dashatan N, Koushki M, Jalilian A, et al. Integrated Bioinformatics Analysis of mRNAs and miRNAs Identified Potential Biomarkers of Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev, 2020, 21(6): 1841-1848. DOI:10.31557/APJCP.2020.21.6.1841
    5. Xu GQ, Li LH, Wei JN, et al. Identification and profiling of microRNAs expressed in oral buccal mucosa squamous cell carcinoma of Chinese hamster. Sci Rep, 2019, 9(1): 15616. DOI:10.1038/s41598-019-52197-3
    6. Li CY, Zhang WW, Xiang JL, et al. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma. Oncol Rep, 2019, 42(6): 2583-2599. DOI:10.3892/or.2019.7377
    7. Zhong L, Liu Y, Wang K, et al. Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma. BMC Cancer, 2018, 18(1): 911. DOI:10.1186/s12885-018-4806-7
    8. Willett CS, Wilson EM. Evolution of Melanoma Antigen-A11 (MAGEA11) During Primate Phylogeny. J Mol Evol, 2018, 86(3-4): 240-253. DOI:10.1007/s00239-018-9838-8
    9. Li J, Zhou D, Qiu W, et al. Application of Weighted Gene Co-expression Network Analysis for Data from Paired Design. Sci Rep, 2018, 8(1): 622. DOI:10.1038/s41598-017-18705-z
    10. Mallik S, Zhao Z. ConGEMs: Condensed Gene Co-Expression Module Discovery Through Rule-Based Clustering and Its Application to Carcinogenesis. Genes (Basel), 2017, 9(1): 7. DOI:10.3390/genes9010007
    11. Irimie AI, Braicu C, Pileczki V, et al. Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells. Mol Cell Biochem, 2016, 419(1-2): 75-82. DOI:10.1007/s11010-016-2751-9

    Other cited types(0)

Catalog

    Article Metrics

    Article views (3451) PDF downloads (625) Cited by(11)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return